A CONTINUOUS SEQUENCE OF MORE THAN 70 AMINO-ACIDS IS ESSENTIAL FOR ANTIBODY-BINDING TO THE DOMINANT ANTIGENIC SITE OF GLYCOPROTEIN GP58 OF HUMAN CYTOMEGALOVIRUS

被引:70
作者
WAGNER, B
KROPFF, B
KALBACHER, H
BRITT, W
SUNDQVIST, VA
OSTBERG, L
MACH, M
机构
[1] UNIV ERLANGEN NURNBERG, INST KLIN & MOLEC VIROL, LOSCHGESTR 7, W-8520 ERLANGEN, GERMANY
[2] UNIV TUBINGEN, MED NAT WISSENSCHAFTLICHES FORSCHUNGZENTRUM, W-7400 TUBINGEN 1, GERMANY
[3] UNIV ALABAMA, DEPT PEDIAT, BIRMINGHAM, AL 35294 USA
[4] NATL BACTERIOL LAB, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[5] KAROLINSKA INST, S-10521 STOCKHOLM, SWEDEN
[6] SANDOZ INC, RES INST, E HANOVER, NJ 07936 USA
关键词
D O I
10.1128/JVI.66.9.5290-5297.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antigenic domain 1 (AD-1) on glycoprotein gp58 of human cytomegalovirus was characterized in detail, using mouse and human monoclonal antibodies as well as human convalescent sera. Series of procaryotically expressed fusion proteins and synthetic peptides of various lengths were used as sources of antigen. Binding of antibodies was found to depend on a continuous sequence of more than 70 amino acids between residues 552 and 635 of gp58. The fine specificities for sequences involved in antibody binding were (i) amino acids 557 to 635 for neutralizing as well as nonneutralizing mouse monoclonal antibodies, (ii) amino acids 552 to 630 for a neutralizing human monoclonal antibody, and (iii) amino acids 557 to 630 for antibodies present in human sera. Experiments involving fragments of AD-1, presented either as procaryotically expressed fusion protein or as synthetic peptides, indicated that the intact structure was required for recognition of AD-1 by antibodies.
引用
收藏
页码:5290 / 5297
页数:8
相关论文
共 42 条
[1]   PRIMARY CYTOMEGALO-VIRUS INFECTION IN PREGNANCY - COMPARISON OF ANTIBODY-RESPONSES TO VIRUS-ENCODED PROTEINS BETWEEN WOMEN WITH AND WITHOUT INTRAUTERINE INFECTION [J].
ALFORD, CA ;
HAYES, K ;
BRITT, W .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (05) :917-924
[2]   A RAPID MICRONEUTRALIZATION ASSAY FOR THE MEASUREMENT OF NEUTRALIZING ANTIBODY REACTIVE WITH HUMAN CYTOMEGALO-VIRUS [J].
ANDREONI, M ;
FAIRCLOTH, M ;
VUGLER, L ;
BRITT, WJ .
JOURNAL OF VIROLOGICAL METHODS, 1989, 23 (02) :157-167
[3]   SYNTHESIS AND PROCESSING OF THE ENVELOPE GP55-116 COMPLEX OF HUMAN CYTOMEGALOVIRUS [J].
BRITT, WJ ;
AUGER, D .
JOURNAL OF VIROLOGY, 1986, 58 (01) :185-191
[4]   CELL-SURFACE EXPRESSION OF HUMAN CYTOMEGALOVIRUS (HCMV) GP55-116 (GB) - USE OF HCMV-RECOMBINANT VACCINIA VIRUS-INFECTED CELLS IN ANALYSIS OF THE HUMAN NEUTRALIZING ANTIBODY-RESPONSE [J].
BRITT, WJ ;
VUGLER, L ;
BUTFILOSKI, EJ ;
STEPHENS, EB .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1079-1085
[6]   PROCESSING OF THE GP55-116 ENVELOPE GLYCOPROTEIN COMPLEX (GB) OF HUMAN CYTOMEGALO-VIRUS [J].
BRITT, WJ ;
VUGLER, LG .
JOURNAL OF VIROLOGY, 1989, 63 (01) :403-410
[7]   GENETIC-CONTROL AND FINE SPECIFICITY OF THE IMMUNE-RESPONSE TO A SYNTHETIC PEPTIDE OF INFLUENZA-VIRUS HEMAGGLUTININ [J].
BROWN, LE ;
MURRAY, JM ;
ANDERS, EM ;
TANG, XL ;
WHITE, DO ;
TREGEAR, GW ;
JACKSON, DC .
JOURNAL OF VIROLOGY, 1988, 62 (05) :1746-1752
[8]  
CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
[9]   ANALYSIS OF INTERSTRAIN VARIATION IN CYTOMEGALOVIRUS GLYCOPROTEIN-B SEQUENCES ENCODING NEUTRALIZATION-RELATED EPITOPES [J].
CHOU, SW ;
DENNISON, KM .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1229-1234
[10]   IDENTIFICATION OF THE HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B GENE AND INDUCTION OF NEUTRALIZING ANTIBODIES VIA ITS EXPRESSION IN RECOMBINANT VACCINIA VIRUS [J].
CRANAGE, MP ;
KOUZARIDES, T ;
BANKIER, AT ;
SATCHWELL, S ;
WESTON, K ;
TOMLINSON, P ;
BARRELL, B ;
HART, H ;
BELL, SE ;
MINSON, AC ;
SMITH, GL .
EMBO JOURNAL, 1986, 5 (11) :3057-3063